News Article and Medical Journal

Prevention and treatment strategies against risks of influenza complications are needed to improve outcomes for those at highest risk of influenza virus emerge. Herein we provide you with informations about the clinical complications of viral influenza (influenza A-H1N1 and H3N2, influenza B)

What you will find within the article are sections discuss about Individual influenza infection risk stratification, Clinical influenza significance, Pulmonary complications of viral influenza, Primary influenza virus pneumonia, Secondary Bacterial Pneumonia, Pulmonary complications with unusual pathogens, Exacerbations of Chronic Lung Diseases, Miscellaneous Complications of Viral Influenza, Impact of prevention and treatment on complications (vaccine, and antiviral medication).

Clinical Complications of Influenza Virus Infection continued »

HIV/AIDS programmes and services should be aware about the potensial and relevant risks regarding the influenza A (H1N1) virus infection as well it needs to consider plans for prevention and treatment. There is lack of information on clinical interactions between HIV and influenza A (H1N1) virus including whose transmission, complications, and spectrum of illness that the increased risk of complications of influenza A (H1N1) are under investigation.

Pan American Health Organization which is a regional office of the WHO issued Considerations on Influenza A (H1N1) and HIV infection at May 1, 2009. It was stated that the risk of mortality from seasonal influenza is increased among HIV-infected individuals compared with the general population. Therefore, HIV patients need to be considered as a high risk and a priority for antiviral treatment with oseltamivir or zanamivir which shortens illness duration and severity in seasonal influenza.

Correlation Between Influenza A (H1N1) Infection with HIV/AIDS continued »

Current seasonal influenza vaccines are not likely to provide protection against novel influenza A (H1N1) virus even the signs and symptoms of novel influenza A (H1N1) virus infection are similar to those of seasonal influenza. Therefore, a licensed specific influenza A (H1N1) virus vaccine is being manufactured and expected to be ready in US by mid-October 2009. Since the vaccines might not be enough to supply the demand, herein the CDC recommendation to use these vaccines.

This recommendations was prepared by CDC’s Advisory Committee on Immunization Practices (ACIP). Accordingly, the principle in this recommendations is to vaccinate as many persons as quickly as possible. You will find sections describe you with the background on the use of Influenza A (H1N1) vaccine (clinical features, age group of persons hospitalized with laboratory-confirmed influenza in US, Epidemiology and Transmission of Influenza A (H1N1)).

The CDC Recommendations Use of Influenza A (H1N1) 2009 Monovalent Vaccine continued »

Many different types of brain damage from various cause may result in an increased intracranial pressure (ICP). Herein we provide you with an article reviews the pathophysiology of Increased Intracranial Pressure and common clinical features of intracranial hypertension in children. According to the article, conditions that may lead to an increased intracranial pressure are hydrocephalus, stroke, tumor, venous sinus thrombosis, or hemorrhage although Traumatic Brain Injury (TBI) still the most common cause of intracranial hypertension.

You will find brief review about intracranial hypertension pathophysiology and discuss sections such Herniation Syndromes, Guidelines for treatment of increased ICP in the pediatric population, Increased intracranial pressure monitoring in children, Positioning to reduce ICP, Sedation and Analgesia for intracranial hypertension therapies, Hyperosmolar Solution Therapy, Hyperventilation Method, Barbiturates, Drainage of CSF, The use of mild to moderate hypothermia, Surgical interventions, and Other Therapies.

The Pathophysiology of Increased Intracranial Pressure in Children continued »